Skip to main content
Equibles
DMIIR logo

DMIIR · Drugs Made In America Acquisition II Corp.

Track DMIIR — free

Use DMIIR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DMIIR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.07 At close · Oct 21
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“management has determined that these conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”
View the 10-Q filed Aug 14, 2026
Market Cap
$649.42M
Shares
63.70M
Volume · Oct 21 87.57K Avg daily vol (3M) 24.86K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.07 Open$0.07 Day$0.06–0.07 Available close range$0.06–0.10 Avg vol 30d30K DataJul 2026–Oct 2026 Filing10-Q · Aug 14

The closing range uses available history since Jul 23, 2026; less than a full year is stored.

Up next

Latest filing: 10-Q
filed Aug 14, 2026

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
3 of 85 funds reported for Sep 30 · net 0 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
85 holders — near 1-yr high, broad support
Price context
position in its available closing range
Range low $0 Now $0 · 33% Range high $0

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Shell Companies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
DMIIR
Drugs Made In America Acquisition II Corp.
this stock
$649.42M — — — —
VYLR
Vylor Inc.
 $49.34B — — — 2.2%
CLUS
Cluster Group Holdings Ltd Co
 $8.00B — — — —
EVAC
EQV Ventures Acquisition Corp. II
 $604.35M +3.1% — — 0.0%
BCSS
Bain Capital GSS Investment Corp.
 $596.26M +1.3% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders
Holders
85
% held
141.3%
Reported
3 of 85
Top holder
Karpus Management, Inc.
Held Float
View
Held by Funds
Fund positions
1
View
Short & Settlement
Fails to Deliver
FTD shares
308
Value
$3.1K
As of
Sep 15, 2026
View
Financials
Financials
Net income (FY)
$4.2M
View
Filings
SEC Filings
Latest
10-Q
Filed
Aug 14, 2026
This year
8
View

Performance

5D 20D 120D MTD YTD
DMIIR -6.4% -12.5% — +9.0% —
SPY +0.5% +0.7% +7.6% +1.4% +13.4%
vs SPY -6.9% -13.2% — +7.7% —
Key facts CIK 2040475 CUSIP G2851K104 13F (30d) 1 filings 1 filers